Moleculin Biotech Inc. (MBRX)
NASDAQ · Healthcare
Moleculin Biotech Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -25.1M | -26.6M | -29.6M | -30.6M | -23.0M | -19.7M |
| EBITDA | -16.5M | -30.8M | -28.5M | -31.8M | -29.5M | -21.9M |
| Net Income | -33.6M | -21.8M | -29.8M | -29.0M | -15.9M | -17.4M |
| Per Share Data | ||||||
| EPS (diluted) | $-28.42 | $-158.00 | $-15.15 | $-15.15 | $-8.85 | $-26.40 |
| Shares Outstanding (dil.) | 1M | 0M | 2M | 2M | 2M | 1M |
Moleculin Biotech Inc. Income Statement — FAQ
Moleculin Biotech Inc. (MBRX) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MBRX's income statement history?
The chart and table above show Moleculin Biotech Inc.'s income statement by year and by quarter, including the growth rate.